košarica
0.00 €Sermorelin
5 mg98.5% purityLot #SERMOR-2026-001
Šifra izbrane dimenzije: PEP-SERM-5MG
Sermorelin (GRF 1-29) is a laboratory-produced peptide modeled after the first 29 amino acids of the body's natural growth hormone-releasing hormone (GHRH). By acting directly on the pituitary gland, it encourages the natural synthesis and release of human growth hormone (hGH) while maintaining the body's built-in hormonal control systems. Unlike direct HGH administration, Sermorelin relies on physiological feedback mechanisms, helping prevent unnaturally elevated growth hormone levels. Previously marketed as Geref®, it received FDA approval for the diagnosis and treatment of growth hormone deficiency in pediatric patients. Scientific investigations have linked Sermorelin therapy to improvements in lean muscle mass, sleep quality, insulin sensitivity, and overall vitality. Because pituitary feedback remains intact, its safety profile is generally viewed as more favorable than that of exogenous HGH replacement.
€91.50z DDV
✅ Na zalogi (40)
Količinski popusti
| Količina | Cena / kos | Prihranek |
|---|---|---|
| 1 vial | 91.50 € | — |
| 3 vials (−7%) | 85.40 € | −7% |
| 5 vials (−12%) | 80.52 € | −12% |
Ocene in mnenja
Prijavite se in ocenite izdelek po prejetem naročilu. prijava
Certifikat analize
Lab Verified✓Ogled COA pred nakupom — transparentnost zagotovljena
Raziskovalni profil
Sermorelin — znanstveni profil
Vsebina je namenjena izobraževalnim in raziskovalnim namenom. Research Use Only.
- Sermorelin (GRF 1-29) is a laboratory-produced peptide modeled after the first 29 amino acids of the body's natural growth hormone-releasing hormone (GHRH). By acting directly on the pituitary gland, it encourages the natural synthesis and release of human growth hormone (hGH) while maintaining the body's built-in hormonal control systems. Unlike direct HGH administration, Sermorelin relies on physiological feedback mechanisms, helping prevent unnaturally elevated growth hormone levels. Previously marketed as Geref®, it received FDA approval for the diagnosis and treatment of growth hormone deficiency in pediatric patients. Scientific investigations have linked Sermorelin therapy to improvements in lean muscle mass, sleep quality, insulin sensitivity, and overall vitality. Because pituitary feedback remains intact, its safety profile is generally viewed as more favorable than that of exogenous HGH replacement.
